These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 3486300)

  • 41. Trimetazidine-induced enhancement of myocardial glucose utilization in normal and ischemic myocardial tissue: an evaluation by positron emission tomography.
    Mody FV; Singh BN; Mohiuddin IH; Coyle KB; Buxton DB; Hansen HW; Sumida R; Schelbert HR
    Am J Cardiol; 1998 Sep; 82(5A):42K-49K. PubMed ID: 9737485
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Appropriate uptake period for myocardial PET imaging with 18F-FDG after oral glucose loading].
    Brink I; Nitzsche EU; Mix M; Schindler T; Hentschel M; Högerle S; Moser E
    Nuklearmedizin; 2003 Feb; 42(1):39-44. PubMed ID: 12601453
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Diagnostic promise of positron tomography.
    Sobel BE
    Am Heart J; 1982 Apr; 103(4 Pt 2):673-81. PubMed ID: 6978057
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Positron emission tomography is a useful tool in differentiating idiopathic from ischemic dilated cardiomyopathy.
    Boff GM; Zanco P; Della Valentina P; Cardaioli P; Thiene G; Chioin R; Dalla Volta S
    Int J Cardiol; 2000 Jun; 74(1):67-74; discussion 75-6. PubMed ID: 10854681
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Noninvasive measurements of myocardial oxygen consumption--can we do better?
    Gropler RJ
    J Am Coll Cardiol; 2003 Feb; 41(3):468-70. PubMed ID: 12575977
    [No Abstract]   [Full Text] [Related]  

  • 46. Myocardial ischemia (second of three parts).
    Hillis LD; Braunwald E
    N Engl J Med; 1977 May; 296(18):1034-41. PubMed ID: 321964
    [No Abstract]   [Full Text] [Related]  

  • 47. F-18 deoxyglucose and stress N-13 ammonia positron emission tomography in anterior wall healed myocardial infarction.
    Fudo T; Kambara H; Hashimoto T; Hayashi M; Nohara R; Tamaki N; Yonekura Y; Senda M; Konishi J; Kawai C
    Am J Cardiol; 1988 Jun; 61(15):1191-7. PubMed ID: 3259830
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Whole heart distribution of myocardial perfusion, metabolism and myocardial viability by positron emission tomography.
    Araujo LI; Maseri A
    Br Med Bull; 1989 Oct; 45(4):922-32. PubMed ID: 2695219
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Decreased myocardial free fatty acid uptake in patients with idiopathic dilated cardiomyopathy: evidence of relationship with insulin resistance and left ventricular dysfunction.
    Tuunanen H; Engblom E; Naum A; Scheinin M; Någren K; Airaksinen J; Nuutila P; Iozzo P; Ukkonen H; Knuuti J
    J Card Fail; 2006 Oct; 12(8):644-52. PubMed ID: 17045185
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Beta-methyl[1-11C]heptadecanoic acid: a new myocardial metabolic tracer for positron emission tomography.
    Livni E; Elmaleh DR; Levy S; Brownell GL; Strauss WH
    J Nucl Med; 1982 Feb; 23(2):169-75. PubMed ID: 6977020
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Substrate use in ischemic and reperfused canine myocardium: quantitative considerations.
    Myears DW; Sobel BE; Bergmann SR
    Am J Physiol; 1987 Jul; 253(1 Pt 2):H107-14. PubMed ID: 3605356
    [TBL] [Abstract][Full Text] [Related]  

  • 52. An evaluation of myocardial fatty acid and glucose uptake using PET with [18F]fluoro-6-thia-heptadecanoic acid and [18F]FDG in Patients with Congestive Heart Failure.
    Taylor M; Wallhaus TR; Degrado TR; Russell DC; Stanko P; Nickles RJ; Stone CK
    J Nucl Med; 2001 Jan; 42(1):55-62. PubMed ID: 11197981
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The value of positron emission tomography (PET) in cardiologic diagnosis].
    Henze E
    Internist (Berl); 1990 May; 31(5):338-40. PubMed ID: 2380010
    [No Abstract]   [Full Text] [Related]  

  • 54. Functional recovery after coronary revascularization for chronic coronary artery disease is dependent on maintenance of oxidative metabolism.
    Gropler RJ; Geltman EM; Sampathkumaran K; Pérez JE; Moerlein SM; Sobel BE; Bergmann SR; Siegel BA
    J Am Coll Cardiol; 1992 Sep; 20(3):569-77. PubMed ID: 1512335
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Differentiating cardiomyopathy of coronary artery disease from nonischemic dilated cardiomyopathy utilizing positron emission tomography.
    Mody FV; Brunken RC; Stevenson LW; Nienaber CA; Phelps ME; Schelbert HR
    J Am Coll Cardiol; 1991 Feb; 17(2):373-83. PubMed ID: 1991893
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Myocardial positron emission tomography (PET) with fluorodeoxyglucose-18F].
    Grupo PET de la SEMN
    Rev Esp Med Nucl; 2002 Jul; 21(4):301-3. PubMed ID: 12206747
    [No Abstract]   [Full Text] [Related]  

  • 57. Cardiac resynchronization therapy homogenizes myocardial glucose metabolism and perfusion in dilated cardiomyopathy and left bundle branch block.
    Nowak B; Sinha AM; Schaefer WM; Koch KC; Kaiser HJ; Hanrath P; Buell U; Stellbrink C
    J Am Coll Cardiol; 2003 May; 41(9):1523-8. PubMed ID: 12742293
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Myocardial kinetics of 123I-labeled-16-hexadecanoic acid.
    Okada RD; Elmaleh D; Werre GS; Strauss HW
    Eur J Nucl Med; 1983; 8(5):211-7. PubMed ID: 6873097
    [No Abstract]   [Full Text] [Related]  

  • 59. [Results of fatty acid SPECT of the myocardium in coronary disease].
    Reske SN; Knapp FF; Nitsch J; Kropp J; Reichmann K; Winkler C
    Nuklearmedizin; 1986 Jun; 25(3):90-8. PubMed ID: 3489223
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Features of positron emission tomography as a probe for myocardial chemistry.
    Schelbert HR
    Eur J Nucl Med; 1986; 12 Suppl():S2-10. PubMed ID: 3490372
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.